greeksoup/ stock research
Stock research / United States / SNY / Year to 31 December 2020

Sanofi (SNY) annual results, year to 31 December 2020: revenue EUR 36,041 million, from the 20-F

Sanofi files a 20-F with the SEC once a year, in euros. In the year to 31 December 2020 it reported revenue from the sale of goods of EUR 36,041 million ($41.1 billion at the year's average rate), down 0.2% on the year before. Its profit attributable to shareholders was EUR 12,294 million, up 346.4%, and diluted earnings per share EUR 9.77.

Revenue
EUR 36,041 million
-0.2% on the year
FY2015FY2020
Operating margin
39.2%
8.4% a year earlier
FY2015FY2020
Net income
EUR 12,294 million
+346.4% on the year
FY2015FY2020
Diluted EPS
EUR 9.77
+338.1% on the year
FY2015FY2020

this yearthe year beforeIn euros as filed. Hover a bar for its figure.

Income statement (profit and loss)

Year toDec 2019 †Dec 2020 †
Revenue from the sale of goods36,12636,041
Cost of sales11,97912,159
Gross profit25,65225,210
Research and development6,0205,530
Selling, general and administrative9,8849,391
Operating profit3,05114,113
Finance costs440388
Income tax1211,807
Profit for the year2,78512,330
Profit attributable to shareholders2,75412,294
Filing20-F20-F
EUR million, from the 20-F on the SEC's EDGAR, linked in the last row, on the IFRS tags the company filed.
Read moreA line the company does not file under the standard tag is left out rather than estimated.
Year toDec 2019 †Dec 2020 †
Diluted EPS2.239.77
Basic EPS2.249.82
Filing20-F20-F

EUR per ordinary share, as filed.

Cash flow

Year toDec 2019 †Dec 2020 †
Cash from operations7,7157,418
Cash from investing-1,1833,619
Cash from financing-4,193-6,485
Buybacks9.0822
Dividends paid3,8343,937
Filing20-F20-F

EUR million. Free cash flow is cash from operations less the purchase of property, plant and equipment, arithmetic on the two filed lines.

Balance sheet

Year toDec 2019 †Dec 2020 †
Funded by
Equity attributable to shareholders59,05663,106
Non-controlling interests174146
Borrowings, as filed24,56822,631
Lease liabilities1,1632,108
Other liabilities27,66926,422
Total equity and liabilities112,630114,413
Owned
Property, plant and equipment9,7179,365
Goodwill44,51944,364
Other intangible assets16,50918,341
Cash and cash equivalents9,42713,915
Inventories7,9948,352
Other assets24,46420,076
Total assets112,630114,413
Filing20-F20-F

EUR million, at each fiscal year end.

Ratios on the filed lines

Year toDec 2019 †Dec 2020 †
Return on year-end equity4.7%19.5%
Filing20-F20-F

Arithmetic on the filed lines of the same year.

20-F for the year to 31 December 2020, filed 24 February 2023: the filing. The figures are in euros as filed.